We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Delving Into Glycogen Storage Diseases
Blog

In this interview, Gaia Fancellu, of Iceni Diagnostics, talks about her work in more detail, discusses the challenges of studying GSDs, and highlights the advantages of using a “Systems Medicine” approach to do so.

Read More

Reducing Errors in Whole Genome Sequencing: It Starts With Library Prep
Blog

The highly complex process of whole genome sequencing comes with a high cost of error. One pipetting or mixing mistake can lead to costly errors downstream. When working with multiple samples, error-free sample handling and proper mixing becomes even more critical. The first step in the process to prepare the sample for sequencing, library prep, is a vital step that, if not done correctly, can lead to flawed data and costly delays.

Read More

Detecting the Presence of Cancer in Patients’ Breath
Blog

Thermo Fisher Scientific and Owlstone Medical have recently entered a collaboration, with the aim of advancing breath diagnostics for the early diagnosis of cancer and other diseases. Dr Max Allsworth, Chief Science Officer, Owlstone Medical, and Dominic Roberts, Product Marketing Manager, Orbitrap GC-MS, Thermo Fisher Scientific tell us more about the collaboration and the advantages that breath biopsies can bring to disease detection.

Read More

Using Protein Biomarkers Increases the Chances of Success in Clinical Trials
Blog

Many clinical trials fail due to lack of efficacy. But while some of this may be due to poor target selection during the drug discovery process, it’s becoming increasingly clear that only certain patients respond to treatments. So how exactly does precision medicine increase the likelihood of success in clinical trials?

Read More

Simplifying Next-generation Sequencing in the Clinic
Blog

We recently spoke to Luca Quagliata, Ph.D., Global Head of Medical Affairs for Clinical NGS and Oncology at Thermo Fisher Scientific, to discuss some of the barriers preventing full adoption of NGS-based genomic testing in hospitals, and learn more about a solution that can help to address these.

Read More

Behind the Scenes of MRI-based Liver Disease Diagnostics
Blog

Early diagnosis of liver disease can be life-saving, particularly because the liver has an amazing capacity to regenerate – so it is possible to curb highly prevalent diseases such as fatty liver disease by making lifestyle changes. By taking advantage of magnetic resonance imaging (MRI), Perspectum Diagnostics are developing ways to improve diagnosis in the clinic and accelerate drug discovery.

Read More

Tackling Immune Dysregulation – A Key Driver of Disease
Blog

Immune dysregulation plays a central role in many pathologies. We spoke with Dr Fabienne Charrier-Savournin, from Cisbio, to learn more about the mechanisms underpinning immune dysregulation and how this knowledge is applied for therapeutic intervention.

Read More

Detecting Sepsis Early
Blog

We recently spoke to Elena Sukhacheva, Director Medical and Scientific Affairs at Beckman Coulter, to learn about some of the challenges of diagnosing sepsis early, and how measuring Monocyte Distribution Width can be used as a sepsis biomarker to aid the process.

Read More

Mass Spectrometry in the Clinical Lab: The Importance of Choosing a Medical Device
Blog

In this interview, SCIEX’s Francis Fung highlights the benefits that mass spectrometry can bring to clinical laboratories, and discusses why when selecting a mass spectrometer, it is important to consider choosing a medical device.

Read More

Thermo Fisher Scientific Joins the Pistoia Alliance
Blog

Recently, Thermo Fisher Scientific announced its membership of the Pistoia Alliance. At the Lab of the Future Congress 2019, we spoke with members of the Thermo Fisher team to learn more about the goals of joining the alliance, and what innovation means to Thermo Fisher.

Read More